Targeting PFKFB3 to enhance CDK4/6 inhibitor response in ER+ breast cancer. Telang S, Clem BF, Miret AAH, Price L, et al. Breast Cancer Res 2026 Jun 25. doi: 10.1186/s13058-026-02336.

Read + Share

Amedeo Smart

Independent Medical Education

Telang S, Clem BF, Miret AAH, Price L, et al. Targeting PFKFB3 to enhance CDK4/6 inhibitor response in ER+ breast cancer. Breast Cancer Res 2026 Jun 25. doi: 10.1186/s13058-026-02336.
PMID: 42343408